DMK PHARMACEUTICALS CORPORATION Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2023-06-12: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; Date of first sale 2023-05-25; Total offering amount Indefinite.
- 2022-07-07: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2022-07-05; Total offering amount $300,000.
- 2020-06-30: Federal exemption Rule 506(b); Types of securities offered Equity; SecurityToBeAcquired; Date of first sale 2020-06-12; Total offering amount $590,000.
- 2020-03-06: Federal exemption Rule 506(b); Types of securities offered OptionToAcquire; SecurityToBeAcquired; Date of first sale 2020-02-21; Total offering amount $6,090,000.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2023-06-12 | Rule 506(b) | Equity; OptionToAcquire | 2023-05-25 | Indefinite | $0 | Indefinite | 12 |
| 2022-07-07 | Rule 506(b) | Equity; OptionToAcquire; SecurityToBeAcquired | 2022-07-05 | $300,000 | $300,000 | $0 | 1 |
| 2020-06-30 | Rule 506(b) | Equity; SecurityToBeAcquired | 2020-06-12 | $590,000 | $590,000 | $0 | 1 |
| 2020-03-06 | Rule 506(b) | OptionToAcquire; SecurityToBeAcquired | 2020-02-21 | $6,090,000 | $6,090,000 | $0 | 2 |
| 2013-07-11 | Rule 506 | Debt; OptionToAcquire; Convertible Debentures | 2013-06-26 | $6,502,158 | $6,502,158 | $0 | 11 |
| 2013-04-24 | Rule 506 | Debt; Convertible Debentures | 2013-04-05 | $575,000 | $575,000 | $0 | 2 |
| 2012-07-09 | Rule 506 | Debt; Convertible and Senior Convertible Notes and the underlying shares of capital stock issuable on conversion thereof. | 2012-06-11 | $1,000,000 | $1,000,000 | $0 | 2 |
| 2012-04-06 | Rule 506 | Equity; Debt; SecurityToBeAcquired | 2011-06-30 | $3,299,920 | $3,299,920 | $0 | 2 |